Financing of health systems to achieve the health Millennium Development Goals in low-income countries

Lancet
Robert FryattAnders Nordstrom

Abstract

Concern that underfunded and weak health systems are impeding the achievement of the health Millennium Development Goals in low-income countries led to the creation of a High Level Taskforce on Innovative International Financing for Health Systems in September, 2008. This report summarises the key challenges faced by the Taskforce and its Working Groups. Working Group 1 examined the constraints to scaling up and costs. Challenges included: difficulty in generalisation because of scarce and context-specific health-systems knowledge; no consensus for optimum service-delivery approaches, leading to wide cost differences; no consensus for health benefits; difficulty in quantification of likely efficiency gains; and challenges in quantification of the financing gap owing to uncertainties about financial commitments for health. Working Group 2 reviewed the different innovative mechanisms for raising and channelling funds. Challenges included: variable definitions of innovative finance; small evidence base for many innovative finance mechanisms; insufficient experience in harmonisation of global health initiatives; and inadequate experience in use of international investments to improve maternal, newborn, and child health. The various...Continue Reading

References

Mar 16, 2002·Science·Prabhat JhaJeffrey D Sachs
Dec 7, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Dan ChisholmShekhar Saxena
Feb 1, 2008·Bulletin of the World Health Organization·Lara J WolfsonJean-Marie Okwo-Bele

❮ Previous
Next ❯

Citations

Nov 2, 2011·Health Policy and Planning·Claude SekabaragaAgnes Soucat
Mar 13, 2012·Health Policy and Planning·Tamara Hafner, Jeremy Shiffman
Nov 21, 2012·Academic Medicine : Journal of the Association of American Medical Colleges·James PfeifferJudith Wasserheit
Apr 13, 2011·PLoS Medicine·Liesl GerntholtzSamantha Willan
Aug 11, 2012·PLoS Medicine·Eliana Jimenez SotoUNKNOWN Investment Case Team for India, Indonesia, Nepal, Papua New Guinea and the Philippines
Jun 12, 2010·Bulletin of the World Health Organization·Robert Fryatt, Anne Mills
Jan 24, 2016·Implementation Science : IS·Denis E Ako-ArreyUNKNOWN AGREE-HS Team
Jan 14, 2011·Lancet·Y BalarajanS V Subramanian
Sep 24, 2015·Ophthalmic Epidemiology·A TafidaUNKNOWN Nigeria National Survey of Blindness and Visual Impairment Study Group
May 12, 2015·Annals of Global Health·Steven J HoffmanUNKNOWN Global Access to Medicines Reform Study Team
Nov 23, 2013·Lancet·Karin StenbergUNKNOWN Study Group for the Global Investment Framework for Women's Children's Health
Jun 17, 2015·International Journal of Health Services : Planning, Administration, Evaluation·Peter DuncanFrancisco Oscar de Siqueira França
Apr 11, 2018·Journal of Biosocial Science·Clifford OdimegwuVesper H Chisumpa
Nov 10, 2017·Health Policy and Planning·Joseph F NaimoliTemitayo Ifafore-Calfee
Dec 3, 2010·PLoS Medicine·Jan H F RemmeRobert F Terry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.